Kailera Therapeutics Deferred Tax Assets and Other Non-Current Assets increased by 105.5% to $5.59M in Q1 2026 compared to the prior quarter.
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
deferred_tax_assets_other_noncurrent| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $2.72M | $5.59M |
| QoQ Change | — | +105.5% |